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 SUMMARY 
Vaccination trials and comparative immunogenicity study using Newcastle disease 
vaccine strain I2 (NDVI2) and NDV La Sota administered to commercial and local 
chickens through intraocular (i/o), intramuscular (i/m), drinking water (dw), untreated 
sorghum, parboiled sorghum, sorghum coated with gum Arabic or commercial chick 
mash feed as vaccine carriers was conducted. Newcastle disease vaccine strain I2 and 
NDV La Sota vaccines provided protection to commercial and local chickens vaccinated 
through i/o, i/m or dw. No significant difference (P≤0.05) was observed in the antibody 
titre of commercial or local chickens vaccinated with either NDVI2 or NDV La Sota 
vaccines administered via commercial feed, parboiled sorghum, parboiled sorghum 
coated with gum Arabic and untreated sorghum. NDVI2 or NDV La Sota vaccines 
administered through commercial feed, parboiled sorghum, parboiled sorghum coated 
with gum Arabic and untreated sorghum gave no or limited protection (0-22%) to the 
birds when challenged with a local strain of velogenic viscerotropic Newcastle disease 
virus Kudu 113 strain. It was concluded that the vaccine carriers used in this study were 











Newcastle disease is the most important 
limiting factor in rural chicken farming in 
most developing countries of the world 
and a serious threat to intensively reared 
chickens (Echeonwu et al., 2008a). A 
thermostable NDVI2 has been 
recommended for use in developing 
countries for the protection of rural 
chickens against ND (Bensink and 
Spradbow, 1999). However, the efficacy 
of this vaccine has not been tested with 
foodstuffs available in rural Nigeria 
(Echeonwu et al., 2008a). Reports from 
elsewhere show varying degrees of success 
with the vaccine in  laboratory and field 
trials (Amakye-Anim et al., 2000; 
Wambura et al., 2000). 
The control of ND in rural poultry can 
make a vital contribution to the 





improvement of household food security 
and poverty reduction in many developing 
countries. Vaccination against ND virus 
(NDV) is routinely practiced throughout 
the world. Intensive poultry farmers in 
Nigeria vaccinate poultry routinely, but 
poultry in extensive production systems 
are not (Sa’idu, 2006).  
In an attempt to make delivery of ND 
vaccine easier to rural chickens different 
types of feed stuffs have already been 
tested as carriers for the vaccine. Not all 
feed stuffs were found to be suitable and 
some staple foods such as sorghum, millet 
and other grains produced in many areas of 
Nigeria have not yet been studied in detail 
(Spradbrow, 1992b; Musa, 2002). The 
objectives of this study were to compare 
the efficacy of NDV I2 and ND La Sota 
vaccine strain administered to local and 
commercial chickens via different routes 
and common feedstuff as possible vaccine 
carriers. 
 
MATERIALS AND METHODS 
Commercial chickens 
One hundred and twenty day old unsexed 
Shika Brown chicks were obtained from 
the Poultry Research Farm, National 
Veterinary Research Institute (NVRI), 
Vom. The chicks were housed in a room 
previously cleaned, washed, disinfected 
and fumigated. They were provided with 
chick mash and water ad libitum. At three 
weeks of age, the birds were identified 
individually with numbered wing tags and 
randomly allocated into twelve 
experimental groups of ten chicks each 
and vaccinated with NDV La Sota or 
NDVI2 vaccines via i/o, i/m, dw, sorghum 
coated with gum Arabic, parboiled 
sorghum, untreated sorghum and a 
commercial chick mash feed. 
 
Local chickens 
One thousand local chicken eggs were 
purchased from live bird markets in Jos 
South and Kanam Local Government 
Areas (LGA) of Plateau State. After 
selection, 876 eggs were found to be 
suitable for incubation. The eggs were then 
candled on the 18
th
 day of incubation. One 
hundred and seventy eight chicks (20.3% 





 day of 
incubation. The chicks were selected on 
the basis of fitness, uniformity and body 
weight. The chicks were identified, 
grouped and vaccinated as outlined for 
commercial chickens. 
 
Vaccine food carriers  
Commercial chick mash feed, sorghum 
and gum Arabic were purchased from a 
market in Bukuru, Jos South LGA of 
Plateau State. 
 
Vaccines and vaccination 
Newcastle disease vaccine strain I2 with a 
titre of 10
10.2
 EID50 per vial and ND  
La Sota vaccine with a titre of 10
9.8
 EID50 
per vial in lyophilized form were obtained 
from the Virology Division of NVRI, 
Vom. A 100 and 200 dose vial of NDVI2 
and NDV LaSota vaccines  were 
reconstituted in 50mls and 100mls of 
normal saline respectively and each  bird 
was given 0.5mls of the reconstituted 
vaccine i/o. For im vaccination, 100 and 
200 dose vials of NDVI2 and NDV La 
Sota vaccines were reconstituted in 20mls 
and 40mls of normal saline respectively 
and each bird was injected with 0.2mls of 
the reconstituted vaccines.  
 
Phytochemical and proximate analysis 
of the food carrier  
Proximate and phytochemical analysis of 
sorghum and gum Arabic was carried out 
as described by AOAC, (1995) in the 
Biochemistry and Molecular Biology 
Division of the NVRI, Vom. 
Preparation and coating of food carrier 
with vaccine virus 
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The method described by Alders and 
Spradbrow (2001), with slight 
modification was used for coating the 
sorghum with vaccine virus. About 100 g 
of gum Arabic was dissolved in 1,000 ml 
of distilled water and boiled for 30 minutes 
and allowed to cool.  One vial of the 
freeze-dried NDVI2 vaccine containing 
100 doses was reconstituted in 10 ml of 
PBS (pH 7.4). Then 40 ml of diluted gum 
Arabic was thoroughly mixed with the 
reconstituted vaccine (100 doses). One 
kilogram of sorghum was added to the 
mixture of the vaccine and gum Arabic 
and thoroughly mixed manually. After 
mixing, the coated food vaccine (Vaccine 
carrier) was spread on metal trays and kept 
at room temperature to dry under gentle air 
current for 30 minutes and 10 g of the 
coated food vaccine was presented to 10 
birds.  
 
Challenge of experimental chickens 
At 3 weeks post vaccination each bird was 
inoculated with 0.20 ml containing 10
6.5
 
EID50/ml of the NDV kudu 113 virus strain 
(Echeonwu et al., 1993) i/m at the leg 
muscle. All birds inoculated were 
observed for two weeks for clinical signs 
and the number of sick and dead in each 
group were recorded.  
 
Serology 
Sera collected were tested for NDV 
antibodies by the haemagglutination 
inhibition tests as described by Allan and 
Gough (1974).  
 
Data Analysis 
Geometric mean of HI antibody titre 
(GMT) and percentage of birds with 
detectable ND antibody were calculated. 
The Statistical Package for Social Sciences 
(SPSS) Programme (version 13) using 
excel was used to determine if there was 
any significance difference between the 
mean HI titre of different groups. 
Morbidity, mortality, case fatality and 




Phytochemical analysis showed that 
tannins and saponins were detected in gum 
Arabic, while anthraquinone and alkaloids 
were in sorghum. Steroids and flavonoids 
were absent in sorghum and gum Arabic, 
while cardiac glycosides were present in 
sorghum and gum Arabic. Sorghum 
contained a higher percentage of crude 
protein (12.0.4%) and crude fibre (8.97%) 
than gum Arabic (4.29% C.P and 5.09% 
crude fibre). 
There were no significant differences 
(P≥0.05) in the prevaccination HI antibody 
titres. Furthermore, there was no 
significant difference (P≥0.05) in HI 
antibody titres in chicks vaccinated with 
NDVI2 or ND La Sota vaccines 
administered through intramuscular route 
or via drinking water at two and three 
week post vaccination. The highest HI 
antibody titre (Log2 6.3+1.3 and Log2 9.8 + 
1.2) were observed in chicks vaccinated 
with ND La Sota via intraocular route 2 
and 3 weeks post vaccination (PV). The 
lowest HI antibody titre (Log2 0.0 + 0.0) 
was observed in unvaccinated control 
group. All the groups responded to 
challenge with velogenic NDV and no 
significant difference in titre was observed 
two weeks post challenge (Table I). The 
highest  HI antibody titre (Log2 7.8+ 0.9 
and Log2 9.3 + 1.4) in local chicks 
vaccinated with NDVI2 or ND La Sota 
vaccine via different routes and vaccine 
carriers was observed at two and three 
weeks PV, respectively in group LCdw 
vaccinated with NDVI2 via drinking water. 
The lowest HI antibody titre (Log2 0.0 + 
0.0) was observed in the unvaccinated 
control group. There was no significant 
difference in HI antibody titre of chicks 
vaccinated via i/o, im, dw and commercial 





feed, parboiled sorghum, parboiled 
sorghum coated with gum Arabic with 
NDVI2 and ND La Sota vaccines. The HI  
antibody titres were also not significantly 
different in birds vaccinated two weeks 




Table I: Geometric mean antibody titres (GMT) in serum of commercial chickens 
vaccinated with NDVI2 or NDV La  Sota vaccine administered through different 




















3 weeks post 
vaccination (n) 
2 weeks post 
challenge  (n) 









(9) 10.8 + 1.6
d 
(9) 









(8) 11.3 + 0.9
d 
(8) 









(8) 11.4 + 0.8
d 
(7) 











(9) 11.7 + 0.6
d 
(2) 











(9) 12.0 + 0.0
d 
(2) 






























CCLi/o NDV La 
Sota   









(10) 11.4 + 0.7
d 
(10) 
CCLi/m NDV La 
Sota 






(8) 6.3 + 1.6
c 
(8) 10.6 + 1.0
d 
(8) 
CCLdw NDV La 
Sota 









(10) 10.6 + 1.9
d 
(10) 




























(n)*  = number of chicks in the group, CC = commercial chicken, i/o = intraocular, i/m = 
intramuscular, dw = drinking water, F= feed, La Sota 
a,b, ab, ac,c  and d  
 = Means with the same 














Table II: Morbidity, mortality case fatality and protection rates in commercial chickens 
vaccinated with NDVI2 or NDV La Sota vaccine administered through 
different routes and vaccine carriers and challenged with a Local strain of 
velogenic NDV intramuscularly. 












CCIi/o NDVI2 Intraocular 0 0 0 100 
CCIi/m NDVI2 Intramuscular 0 0 0 100 
CCIdw NDVI2  Drinking water 30.0 20.0 67.0 78.0 
CCIF1a NDVI2  Commercial 
feed 
100 80.0 80.0 11.0 
CCIF2a NDVI2 Parboiled 
sorghum 
    




100 90.0 90.0 0.0 
CCIF5a NDVI2   Untreated 
sorghum 
    
CCLi/o NDV La 
Sota   
Intraocular 0 0 0 100 
CCLi/m NDV La 
Sota 
Intramuscular 20.0 20.0 67.0 78.0 
CCLdw NDV La 
Sota 
Drinking water 0 0 0 100 




100 90.0 80.0 11.0 
Unvaccinated 
Control 
None None 100 90.0 90.0 10.0 
   CC = commercial chicken, i/o = intraocular, i/m = intramuscular, dw = drinking water, F= 
feed, L= La Sota, I = NDVI2 
 
 
Clinical signs and gross lesions in local 
chickens after challenge were similar to 
those observed in commercial chickens 
and included proventricular and skeletal 
haemorrhages on the breast muscles, 
haemorrhagic enteritis in groups 
vaccinated via commercial feed, sorghum 
coated with gum Arabic, parboiled 
sorghum and unvaccinated controls .  
Commercial and local chickens vaccinated 
with NDVI2 or ND La Sota vaccine 
through i/o, im routes and dw respectively 
had complete (100%) protection against 
challenge with a velogenic NDV. The least 
protected chicks were those vaccinated 
with NDVI2 via commercial feed, 
parboiled sorghum, parboiled sorghum 
coated with gum Arabic and ND La Sota 
vaccine via commercial feed. High 
morbidity (100%), mortality and case 
fatality rates were observed in groups that 
were either vaccinated with NVDI2 or La 
Sota via parboiled sorghum, sorghum 
coated with gum Arabic, untreated 













Table III: Geometric mean antibody titre (GMT) Log2 of Local chickens vaccinated 
with NDVI2 or NDV La Sota vaccine administered through   different routes 
















2 weeks post 
vaccination(n) 
3 weeks post 
vaccination(n) 
2 weeks post challenge 
(n) 





(9) 8.7 + 2.8
 c
(9) 11.0 + 0.8
d 
(9) 





(8) 8.0 + 1.4
 c
(8) 10.9 + 0.8
d 
(8) 





(8) 9.3 + 1.4
 c
(8) 10.3 + 1.0
d 
(8) 


















































LCLi/o NDV La 
Sota   
Intraocular 0.0 + 0.0




(9) 7.3 + 1.7
 c
(9) 9.8 + 2.1
d 
(9) 
LCLi/m NDV La 
Sota 





(9) 5.7 + 3.9
 c
(9) 10.3 + 1.3
d 
(9) 
LCLdw NDV La 
Sota 





























(9) 0.0 + 0.0
 ac 
(9) 12.0 + 0.0
 d
 (2) 
LC = Local chicken, i/o = intraocular, i/m = intramuscular, dw = drinking water, F= feed, L= 
La Sota, I = NDVI2 
 a,b, ab, ac,c  and d  
 = Means with the same letters  in the same column are not 





















Table IV: Morbidity, mortality case fatality and protection rate of Local chickens 
vaccinated with NDVI2 or ND La Sota vaccine   administered through different 
route and vaccine carrier and challenged with Local strain of velogenic NDV  
intramuscularly. 










LCIi/o NDVI2 Intraocular 0 0 0 100 
LCIi/m NDVI2 Intramuscular 0 0 0 100 
LCIdw NDVI2  Drinking water 0 0 0 100 
LCIF1a NDVI2  Commercial feed 100 70.0 87.5 22.0 
LCIF2a NDVI2 Parboiled 
sorghum 
100 70.0 87.5 22.0 
LCIF3a NDVI2 Parboiled 
sorghum coated 
with gum Arabic 
100 70.0 87.5 22.0 
LCIF5a NDVI2   Untreated 
sorghum 
100 80.0 75.0 11.0 
LCLi/o NDV La 
Sota   
Intraocular 0 0 0 100 
LCLi/m NDV La 
Sota 
Intramuscular 0 0 0 100 
LCLdw NDV La 
Sota 
Drinking water 0 0 0 100 
LCLF1a NDV La 
Sota 
Commercial feed 100 90.0 89.0 10.0 
Control None None 100 90.0 100 10.0 
    LC = Local chicken, i/o = intraocular, i/m = intramuscular, dw = drinking water, F= 





The efficacy of any vaccine is determined 
mainly by assessment of the level of 
antibody produced in the target bird and 
the ability of the vaccinated bird to resist 
exposure to the virulent agent when 
compared with unvaccinated control 
(Spradbrow, 1993/1994; Allan et al., 
1978). The suggested and reported 
protective antibody titres for ND vaccines 
are HI ≥ Log2 4 (OIE, 2000). By 
implication, antibody titre less than Log2 4 
may not be protective. The vaccine viruses 
(NDVI2 and NDV La Sota) as observed in 
this study were immunogenic and 
protective only in commercial or local 
chickens that received  the vaccines via 
i/o, im or dw at 3 weeks PV and not 
protective in  birds vaccinated via 
commercial feed, parboiled sorghum, 
parboiled sorghum coated with gum 
Arabic and untreated sorghum. Earlier 
reports on similar investigations showed 
varying outcomes (Aini et al., 1990; 
Echeonwu et al., 2008b). Failure of some 
of these trials using grains was blamed on 
antiviral factors constituent in the seed or 
introduced as preservatives. The presence 
of tannins in sorghum and gum Arabic as 
observed in this study might have been 
responsible for inactivating the vaccine 
virus. As tannins are known to chellates 
ND vaccine virus making it unavailable to 
the birds, this effect of tannins on NDV 
may probably be associated with 
substances that inactivate the NDV and 





with binding to food lectins (Spradbrow, 
1992b).Bioactive chemical compounds 
like saponins present in gum Arabic are 
known to be immune pontentiators in birds 
and other mammals (Hughes et al., 1958). 
Newcastle disease vaccines administered 
orally have been reported to primarily 
provoke mucosal immunity (Jayawardane 
and Spradbrow, 1995). It is thought that 
this is the first line of defense against 
NDV infection, which occurs either by 
inhalation or ingestion or both (Alexander, 
1988). This arm of humoral immunity is 
reported to be responsible for protection of 
the chickens even before detectable HI 
antibody is found in the serum 
(Spradbrow, 1992b). Although OIE (2000) 
recommended HI (log2) titre of Log2 4.0 as 
protective with reference to conventional 
ND vaccines designed for intensively 
reared commercial chickens, HI antibody 
titre of  Log2 3.0  was considered to be 
adequate for food-based vaccines 
administered orally to scavenging chickens 
(Echeonwu et al., 2007). This is more so 
since it has been found that even chickens 
with HI antibody titre of ≤ Log2 3.0 resist 
challenge with velogenic ND virus as 
observed in both the commercial and local 
chickens, indicating that serum antibody 
alone may not be responsible for the 
resistance to challenge.  
Following challenge experiments to assess 
the efficacy of the vaccination method, 
clinical signs of ND observed in the 
chickens were similar to those described 
by Alexander (1997). The gross lesions 
observed were identical with lesions 
described by McFerran and McCraken 
(1988) for Newcastle disease. These 
included haemorrhagic lesions in the small 
intestines, proventriculus and caecal 
tonsils. Other lesions observed were 
tracheal congestion and air sacculitis. 
The challenge experiments did not follow 
the natural routes of infection in the field, 
namely oral by drinking water in line with 
the suggestion of Spradbrow (1993/94) 
that the conventional intramuscular route 
would by-pass the natural route of 
infection in the field. Though, Iroegbu and 
Nchinda (1999) employed the drinking 
water route for challenge experiments with 
satisfactory results, it was however, 
considered in this experiment that for birds 
to receive equal doses of challenge virus 
and to assess the efficacy of vaccination on 
protection of the birds against velogenic 
ND virus in the laboratory, im route was 
considered the method of choice.  
 
CONCLUSIONS 
It was concluded that i/o, i.m, dw routes of 
NDVI2 vaccine administration gave higher 
HI antibody titre and protection rate in 
commercial or local chickens. Untreated 
sorghum, parboiled sorghum, sorghum 
coated with gum Arabic and a commercial 
feed mash when used as feed carriers for 
NDVI2 vaccine gave low antibody titre 
and less protection following challenge 
with velogenic NDV.  
Different processing methods of traditional 
feeds or their offals should be utilized to 
reduce or eliminate possible virucidal 
substances that may be present in feed 
grains which affect the survival of the 
NDVI2 vaccine virus. 
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